The British Society for Genetic Medicine guidance on managing incidental findings identified during rare disease genomic testing.
Clear guidance helps doctors decide which genetic variants to share with patients and which to hold back.
BSGM guidance recommends reporting incidental pathogenic variants with high penetrance and actionable outcomes in rare disease genomic testing, while discouraging routine reporting of heterozygous carrier status for autosomal recessive conditions. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- guidance_document
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- J Med Genet
Why it surfaced
Authoritative national guidance from BSGM on an issue directly relevant to clinical genomics workflows; actionable for NHS laboratories and directly applicable to precision medicine programs globally; high relevance for rare disease pipeline prioritization.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.